CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 50 enrolled
Drug / intervention
Abametapir Lotion 0.74% w/w +1 moredrug
Likely dose
Abametapir Lotion 0.74% w/w 200mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02097485
NCT02097485Phase 2Completed
CompareCT.gov

A Randomised, Double-Blind, Vehicle-Controlled Study of Ovicidal Efficacy and Safety of Abametapir 0.74% Administered for the Treatment of Head Lice Infestation

Dr. Reddy's Laboratories Limited·interventional·Posted Mar 27, 2014·Updated May 11, 2021

In Brief

A Phase 2 clinical trial evaluating Abametapir Lotion 0.74% w/w and Vehicle Lotion for Head Lice Infestation. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The purpose of the study was to evaluate ovicidal efficacy of a single application of abametapir lotion 0.74% w/w intended for the treatment of head lice.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead Lice Infestation
CountriesAustralia
Collaborators--

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 27, 2014
Enrollment StartMay 1, 2014
Primary CompletionSep 1, 2014
Study CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 12.3 years ago

Interventions

Abametapir Lotion 0.74% w/wdrug

200mL abametapir lotion topically administered to the scalp and hair and once fully saturated left for 10 minutes and then washed out thoroughly with warm water.

Vehicle Lotiondrug

control to abametapir: 200mL Vehicle Lotion topically administered to the scalp and hair and once fully saturated left for 10 minutes and then washed out thoroughly with warm water.